Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function...
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Despite the success of current therapies for acute myocardial infarction (MI), many patients still develop adverse cardiac remodeling and heart failure. With the growing prevalence of heart failure, a new therapy is needed that can prevent remodeling and support tissue repair. Herein, we report on injectable recombinant human collagen type I (rHCI)...
Alternative Titles
Full title
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_87f2d71678a14732bc74e04f815a25a6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87f2d71678a14732bc74e04f815a25a6
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-019-12748-8
